Literature DB >> 14534706

Role of tumor-associated macrophages in renal cell carcinoma.

Shinichi Ikemoto1, Naomasa Yoshida, Keisuke Narita, Seiji Wada, Taketoshi Kishimoto, Kazunobu Sugimura, Tatsuya Nakatani.   

Abstract

We investigated the biologic meaning of tumor-associated macrophages (TAM) in renal cell carcinoma (RCC). The study group comprised of 83 patients with RCC. TAM was isolated by plastic adherence following enzymatic digestion of surgically removed tumor tissues. In some of the patients, monocytes were also isolated from peripheral blood mononuclear cells by plastic adherence. When TAM and monocytes were compared in the same patients, TAM produced interleukin 6 (IL-6), tumor necrosis factor alpha (TNFalpha) and interleukin 1beta (IL-1beta) without lipopolysaccharide (LPS) stimulation, while monocytes hardly produced IL-6, TNFalpha and IL-1beta without LPS stimulation. However, with LPS stimulation, monocytes produced more IL-6, TNFalpha and IL-1beta than TAM. In stage T1 RCC patients, there was a significant positive correlation between TNFalpha production of TAM and tumor size. In order to investigate the effects of TAM on cancer cells, TAM was co-cultured with A498, K562 and in some cases, with short-term established RCC lines for 96 h. As a result, TAM largely enhanced cell proliferation. These results suggested that TAM may play an important role in certain steps of tumor progression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534706

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC).

Authors:  Zofia F Bielecka; Anna M Czarnecka; Wojciech Solarek; Anna Kornakiewicz; Cezary Szczylik
Journal:  Curr Signal Transduct Ther       Date:  2014-12

Review 2.  Tumor Associated Macrophages in Kidney Cancer.

Authors:  Olga V Kovaleva; Daria V Samoilova; Maria S Shitova; Alexei Gratchev
Journal:  Anal Cell Pathol (Amst)       Date:  2016-10-11       Impact factor: 2.916

3.  IL1 genes polymorphism and the risk of renal cell carcinoma in Chinese Han population.

Authors:  Fei Wang; Yingai Zhang; Shunlan Wang; Yadong Zhang; Dinglan Wu; Chong Zhang; Yuanhui Gao; Xi Liu; Weifu Wang; Shufang Zhang
Journal:  Oncotarget       Date:  2017-06-28

4.  Associations between polymorphisms in the IL-4 gene and renal cell carcinoma in Chinese Han population.

Authors:  Hao Rong; Xue He; Li Wang; Yongjun He; Longli Kang; Tianbo Jin
Journal:  Oncotarget       Date:  2017-06-09

5.  The Disturbed Iron Phenotype of Tumor Cells and Macrophages in Renal Cell Carcinoma Influences Tumor Growth.

Authors:  Matthias Schnetz; Julia K Meier; Claudia Rehwald; Christina Mertens; Anja Urbschat; Elisa Tomat; Eman A Akam; Patrick Baer; Frederik C Roos; Bernhard Brüne; Michaela Jung
Journal:  Cancers (Basel)       Date:  2020-02-25       Impact factor: 6.639

6.  Interleukin-1β mediates metalloproteinase-dependent renal cell carcinoma tumor cell invasion through the activation of CCAAT enhancer binding protein β.

Authors:  Brenda L Petrella; Matthew P Vincenti
Journal:  Cancer Med       Date:  2012-06-07       Impact factor: 4.452

7.  Synergistic effects of IL-4 and TNFα on the induction of B7-H1 in renal cell carcinoma cells inhibiting allogeneic T cell proliferation.

Authors:  Dagmar Quandt; Simon Jasinski-Bergner; Ulrike Müller; Bianca Schulze; Barbara Seliger
Journal:  J Transl Med       Date:  2014-05-30       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.